| Male | Female | ||
---|---|---|---|---|
β (95% CI) | P value | β (95% CI) | P value | |
Model 1 | ||||
 TG (mmol/l) | 0.021 (-0.006–0.048) | 0.124 | 0.006 (-0.022, 0.034) | 0.682 |
 TC (mmol/l) | -0.020 (-0.044–0.005) | 0.114 | -0.006 (-0.022, 0.034) | 0.682 |
 ApoA1(g/l) | -0.009 (-0.144–0.125) | 0.889 | -0.066 (-0.146, 0.015) | 0.109 |
 ApoB (g/l) | -0.074 (-0.177–0.030) | 0.161 | 0.005 (-0.083, 0.093) | 0.909 |
 ApoA1/ApoB | 0.021 (-0.042–0.084) | 0.516 | -0.034 (-0.074–0.006) | 0.095 |
 HDL-C (mmol/l) | -0.050 (-0.180–0.080) | 0.445 | -0.053 (-0.137, 0.031) | 0.215 |
 LDL-C (mmol/l) | -0.030 (-0.066–0.006) | 0.099 | 0.005 (-0.025, 0.035) | 0.732 |
 FFA (mmol/l) | -0.195 (-0.334–-0.055) | 0.007* | -0.244 (-0.348, -0.140) | <0.001* |
 IL-6 (pg/ml) | -0.005 (-0.007–-0.002) | 0.002* | -0.007 (-0.009, -0.005) | <0.001* |
Model 2 | ||||
 TG (mmol/l) | 0.017 (-0.009–0.044) | 0.202 | 0.010 (-0.011, 0.032) | 0.343 |
 TC (mmol/l) | -0.027 (-0.051–-0.003) | 0.031* | -0.016 (-0.031, -0.001) | 0.043* |
 ApoA1(g/l) | -0.003 (-0.134–0.128) | 0.961 | -0.062 (-0.123, -0.001) | 0.047* |
 ApoB (g/l) | -0.100 (-0.201–0.001) | 0.053 | -0.047 (-0.115, 0.020) | 0.169 |
 ApoA1/ApoB | 0.040 (-0.023–0.102) | 0.208 | -0.008 (-0.039–0.023) | 0.632 |
 HDL-C (mmol/l) | -0.037 (-0.164–0.089) | 0.558 | -0.062 (-0.125, -0.002) | 0.056 |
 LDL-C (mmol/L) | -0.043 (-0.079–-0.008) | 0.017* | -0.013 (-0.036, 0.009) | 0.248 |
 FFA (mmol/l) | -0.171 (-0.309–-0.033) | 0.016* | -0.102 (-0.189, -0.015) | 0.022* |
 IL-6 (pg/ml) | -0.004 (-0.007–-0.001) | 0.011* | -0.002 (-0.005, 0.001) | 0.033* |